📰 Valuating News
Page 6 - Valuating News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Valuating. Real-time updates on events, politics, business and more.
April 17, 2023
MyJournals.org - Science - Remote Sensing, Vol. 15, Pages 2094: Evaluating the Losses and Recovery of GPP in the Subtropical Mangrove Forest Directly Attacked by Tropical Cyclone: Case Study in Hainan Island (Remote Sensing)
April 17, 2023
Promising anti-tumor activity reported for C-CAR031, a novel Glypican 3 (GPC3)-targeting cell therapy designed by AstraZeneca SHANGHAI, April 17, 2023 /PRNewswire/ -- Shanghai Cellular
April 13, 2023
The Reserve Bank of India has begun evaluating at least five potential bidders interested in picking up a majority stake in state-owned IDBI Bank Ltd, three people familiar with the matter told... | April 13, 2023
April 13, 2023
Tertiary Minerals PLC shares jumped on Thursday, after it said it has raised GBP250,000 to continue evaluating its copper exploration projects portfolio. The Zambia and Nevada, US-focused explorer... | April 13, 2023
April 12, 2023
MAIA Biotechnology, Inc. today announced that it will present a poster that will feature the design of its ongoing Phase 2 clinical trial, THIO-101 evaluating THIO in patients with advanced... | April 12, 2023
April 12, 2023
Our licensing partner Verrica Pharmaceuticals today announced that the first patient has been dosed in Part 2 of their Phase II study evaluating our lead compound, LTX-315 - by Verrica... | April 12, 2023
April 12, 2023
Accepted abstracts include three summarizing findings from separate, large-scale, real-world studies evaluating clinical utility of Decipher Prostate Genomic Classifier ... | April 12, 2023
April 12, 2023
By Kirk Maltais --Corn for May delivery rose 0.8%, to $6.56 a bushel, on the Chicago Board of Trade on Wednesday, with traders evaluating supplies as tight even though the USDA didnt cut its... | April 12, 2023
April 6, 2023
BELLUS Health Inc. announced positive data from its Phase 1 bioavailability equivalence study evaluating a once-daily Extended-Release formulation of camlipixant in comparison to a twice-daily... | April 6, 2023
April 6, 2023
Continued advancement of global patient enrollment with approvals and site activations in the U.S., Switzerland, France, Spain and ItalyEnrollment continuing to progress toward an interim analysis expected